Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|19 CitationsCognitive & SleepFemale-friendly

Selank Dosing Protocol: Anxiolytic Research Guide

Also known as: TP-7, Tuftsin Analog Anxiolytic Peptide

Dose Range
0.15 mcgResearch range
0Typical research window: 0.15 mcg50 mcg

Studied in published research — not a medical recommendation. Primary protocol (Anxiety Study): 0.15% nasal spray, 3x daily.

Protocol at a Glance
How Often
Daily

3x daily

A Typical Run
14 days

Research-reported range; the linked study used a different dose or units.

How It's Taken
Vial

Intranasal

Evidence
Clinical Trials

Published peer-reviewed research & clinical protocols

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

5 mg vial · 2 mL water · 0.3 mL syringe
Concentration: 2.5 mg in every mL (25 mcg per unit)
0u6u12u18u24u30u
Low end: 0.15 mcg0 units

All U-100: 100 units = 1 mL. 33333 doses in the vial at the low end.

Track the doses you run

Save Selank to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Selank supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Ascension Peptides50% OFF AUTO-APPLIED
Batch COAs (Kovera Labs, MZ Biolabs) on product page
US Domestic Vial
50% Off First Order Link
$25.00 net$50.00
10mg Lyophilized Vial
$2.50/mg$5.00/mg retail
Biotech Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$46.00
10mg vial
$4.60/mg
Pure Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDE9544 takes 10% off at checkout
$49.00
10mg vial
$4.90/mg
Core Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$52.00
10mg vial
$5.20/mg
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$55.00
10mg vial
$5.50/mg
Bulletproof BioLabs
ILS Laboratories HPLC COA COA-2026-7UTY-E, lot BPB-2610-001
US Domestic Vial
Vendor-supplied list price (Nov 7, 2026; store requires login)
$55.00
10mg vial
$5.50/mg
Peptyes
Horizon Analytical UPLC-MS COA, lot DPS-4692745 (99.42%); COA names Privilege Bio Labs (Peptyes says: its manufacturer)
US Domestic Vial
List price (verified Nov 11, 2026); code PEPTIDEPROTOCOLS takes 10% off at checkout
$60.00
10mg vial
$6.00/mg
Swift Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$65.99
10mg vial
$6.60/mg
BioLongevity Labs
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$134.97
20mg vial
$6.75/mg
Direct Peptides
COA per store product page
US Domestic Vial
List price (last verified Nov 4, 2026; store now requires sign-in)
$89.00
10mg vial
$8.90/mg
Limitless Peptides
COA per store product page
US Domestic Vial
Code: PEPTIDEPROTOCOLS
$90.00
10mg vial
$9.00/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

2026 FDA 503A Cat-2 UpdateTier 2 — Human Phase 1/2 Clinical Data
Pharmacological Class
Neurotrophic & Neuroregulatory Neuropeptide (BDNF / NGF / GABA Modulator)
Administration Route
Intranasal spray (mucosal BBB delivery) or Under-the-skin injection (SubQ)
2026 FDA & 503A Status
Not FDA-approved. In April 2026, the FDA removed 14 peptides (including BPC-157, Thymosin Beta-4/TB-500, CJC-1295, Ipamorelin, AOD-9604, Semax, Selank, and DSIP) from the Category 2 503A Interim Bulks List pending formal July 2026 PCAC rulemaking. Available as COA-verified research reference standards or via specialized physician telehealth guidance.
WADA Sport Status
Prohibited at All Times (WADA S0 Unapproved Substances & S2.2 Peptide Hormones, Growth Factors & Mimetics)
Evidence Tier
Tier 2 — Human Phase 1/2 Clinical Data: Published human Phase 1/2 clinical studies, regional regulatory approval, or controlled human biomarker trials
What is a Nootropic Peptide?

A peptide that enhances cognitive function — memory, focus, learning, or neuroprotection. Unlike synthetic nootropics (racetams, modafinil), peptide nootropics work through neurotrophic factors like BDNF and NGF. Examples: Semax, Selank, Dihexa, PE-22-28. Most were developed in Russian neuroscience labs.

Bottom Line Up Front

Selank is a Russian anxiolytic peptide developed alongside Semax. It has anxiolytic effects comparable to benzodiazepines without sedation or addiction potential. Modulates GABA and serotonin systems.

Best evidence for

Anxiety, stress reduction, cognitive function under stress

Weakest evidence for

Severe depression, panic disorders

Pharma equivalent

None

Studies on file

19 (3 human)

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Selank is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

Selank is a synthetic peptide derived from tuftsin. It has been studied for its potential anxiolytic and nootropic effects, particularly in stress and anxiety models.

Mechanisms of Action

  • Modulates enkephalin system
  • Influences GABA receptors
  • Anti-anxiety effects
  • Immunomodulatory properties

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
Anxiety Study
reported protocol
0.15% nasal spray3x daily14 daysIntranasalhuman
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (Selank)

Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

hs-CRP (High-Sensitivity C-Reactive Protein)

Day 0 + Wk 6–8

Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.

Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.

ESR (Sedimentation Rate) & Ferritin

Day 0 + Wk 6–8

Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.

Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.

CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)

Day 0 + Wk 6–8

Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).

Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).

CMP (Liver/Kidney) + Serum Copper & Zinc Ratio

Day 0 + Wk 6–8

Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.

Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Related Studies

3 Human16 Animal

Although preclinical studies are promising, there is a current lack of clinical trials. This review integrates current mechanistic insights with orthopaedic relevance, emphasizing safety, efficacy, and future directions for responsible integration into musculoskeletal care.

Limitations: No placebo control reported. Review article — no new primary data.

2026|Journal of the American Academy of Orthopaedic Surgeons. Global research &amp; reviews
PubMed

Single intraperitoneal injection of Selank in an anxiolytic dose of 0.3 mg/kg reduced the total index of morphine withdrawal syndrome by 39.6%, significantly (&#x440;<0.0001) attenuated convulsive reactions, ptosis, and posture disorders, and 9-fold increased the tactile sensitivity threshold in morphine-dependent rats in comparison with the group of active control; at the same time, Selank was slightly inferior to diazepam in a dose of 2 mg/kg by pharmacological activity (the decrease in total index of morphine withdrawal syndrome by 49.3% and 13-fold increase in sensitivity threshold). Thus, Selank, like diazepam, weakens the aversive signs of morphine withdrawal in rats with opiate dependence.

Limitations: Animal study only — human translation uncertain.

2022|Bulletin of experimental biology and medicine
PubMed

As a result of the work performed to determine the concentration of pro-inflammatory and anti- inflammatory cytokines, it was found that in the serum of animals exposed to stress, there was a statistically significant increase in the level of IL-1&#x3b2;, IL-6 and TGF-&#x3b2;1 in individuals with both types of behavior. It should be noted that, under the conditions of this stressful impact, there was a tendency to decrease the concentration of IL-4 and increase the level of TNF-&#x3b1; but these indicators were not statistically significant.

Limitations: Animal study only — human translation uncertain.

2022|Current reviews in clinical and experimental pharmacology
PubMed

At the same time, our results partially confirm the hypothesis that the peptide may affect the interaction of GABA with GABAA receptors. Our data also suggest that Selank may enhance the effect of olanzapine on the expression of the genes studied.

Limitations: Animal study only — human translation uncertain.

2020|Frontiers in pharmacology
PubMed

Administration of Selank in doses of 300 and 1000 &#x3bc;g/kg restored the nucleus/cytoplasm ratio in hepatocytes. The maximum stress-limiting effect was attained after administration of 300 &#x3bc;g/kg Selank.

Limitations: Animal study only — human translation uncertain.

2019|Bulletin of experimental biology and medicine
PubMed

It was shown that Selank affect the [3H]GABA binding as a positive allosteric modulator. The joint action of Selank and some of benzodiazepines also regulates activity of [3H]GABA binding in specific manner, which is not cumulative and differs from either substance individually.

Limitations: Animal study only — human translation uncertain.

2019|Protein and peptide letters
PubMed

Under conditions of chronic stress, Selank in all doses produced similar effects: reduced superoxide dismutase activity and malondialdehyde concentration in the liver tissue and AST activity in the serum. The other parameters remained unchanged.

Limitations: Animal study only — human translation uncertain.

2018|Bulletin of experimental biology and medicine
PubMed

This paper describes eighty-six documents. Thirty-two of them concern on activity of tuftsin in the human organism.

Limitations: No placebo control reported. Review article — no new primary data.

2017|Current medicinal chemistry
PubMed

In conditions of chronic stress, anxiety indicator values after the simultaneous use of diazepam and Selank did not differ from the respective values observed before chronic stress exposure. The data obtained indicate that the individual administration of Selank was the most effective in reducing elevated levels of anxiety, induced by the administration of a course of test substances, whereas the combination of diazepam with Selank was the most effective in reducing anxiety in unpredictable chronic mild stress conditions.

Limitations: Animal study only — human translation uncertain.

2017|Behavioural neurology
PubMed

In some neurons, Selank-induced up-regulation of spontaneous inhibitory postsynaptic currents was preceded by a transient decrease in this activity. In the examined concentration range (1-8 &#x3bc;M), Selank demonstrated no significant dose-dependence.

Limitations: Animal study only — human translation uncertain.

2017|Bulletin of experimental biology and medicine
PubMed

Our results showed that Selank caused a number of alterations in the expression of genes involved in neurotransmission. The data obtained indicate that Selank is characterized by its complex effects on nerve cells, and one of its possible molecular mechanisms is associated with allosteric modulation of the GABAergic system.

Limitations: Animal study only — human translation uncertain.

2016|Frontiers in pharmacology
PubMed

The positive effect of phenazepam was achieved earlier in the optimization of treatment with selank on HDRS. The combined treatment decreased the level of undesirable side-effects of phenazepam (attention and memory impairment, asthenia, sedation, increase in sleep duration, sexual disturbances, emotional indifference and orthostatism) during the course of treatment and after the tranquilizer withdrawal.

Limitations: No placebo control reported.

2015|Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
PubMed

It should be noted that in most cases, there was a coincidence in the expression profiles of the studied genes after Selank and Gly-Pro administration. This might indicate an active contribution of the dipeptide to the final effect of Selank.

Limitations: Animal study only — human translation uncertain.

2014|Molecular immunology
PubMed

The data obtained confirmed the participation of Selank in the processes of regulation of inflammation in the body. The complex biological effect of Selank may be partially determined by the systematic effect of this peptide on genomic expression.

Limitations: Animal study only — human translation uncertain.

2011|Regulatory peptides
PubMed

A high affinity of the studied glyprolines for gastric tissues was found for all the ways of their administration. We suggest that a high efficiency of action of glyprolines on homeostasis of the gastric mucous tunic was partially provided by accumulation of these peptides (to high concentrations) in gastric tissues.

Limitations: Animal study only — human translation uncertain.

2008|Bioorganicheskaia khimiia
PubMed

Selank did not affect the level of general locomotor activity and anxiety in WAG/Rij rats, and did not exert substantial effect on the behavior of control Wistar rats. The results demonstrate the presence of antidepressant component in the spectrum of neuropsychotrophyc activity of selank and indicate the higher reliability of a new experimental model of depression (the WAG/Rij rats) as compared to the standard forced swimming test for the determination of antidepressant activity of a pharmacological drug.

Limitations: Animal study only — human translation uncertain.

2008|Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova
PubMed

The anxiolythic properties of the heptapeptide Selanc that has also been shown to affect the opioid system are most prominent in subjects with elevated activity of enzymes degrading endogenous opioid peptides. Thus, delicate correction of the opioid system with drugs of peptide nature is supposed to become a new approach to treatment of some forms of anxiety disorders accompanied with exhaustion of the endogenous opioid system and, in particular, of generalized anxiety disorder.

Limitations: Animal study only — human translation uncertain.

2007|Vestnik Rossiiskoi akademii meditsinskikh nauk
PubMed

The high doses of peptide (10(-6)--10(-10) M) also augmented the contraction amplitude but decreased its frequency. The maintenance of adequate blood flow and lymphatic vessel contractility can be one of the mechanisms of the Selank antiulcerogenic properties.

Limitations: Animal study only — human translation uncertain.

2005|Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova
PubMed

The dynamic features of the development of the activating action of Selank and piracetam were described. Comparison of the results obtained here with data on the anti-anxiety actions of Selank suggested potential for its use in optimizing mnestic functions in conditions of elevated emotional tension.

Limitations: Animal study only — human translation uncertain.

2003|Neuroscience and behavioral physiology
PubMed

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Prescription drug in Russia
  • •Anxiolytic effects documented
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Selank, baseline labs & clinician oversight.

Full Selank $/mg comparison →
50% OFF AUTO-APPLIED$2.50/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Selank: best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Ascension Peptides — $2.50/mg (10mg Lyophilized Vial, $25.00)
  2. 2. Biotech Peptides — $4.60/mg (10mg vial, $46.00)
  3. 3. Pure Peptides — $4.90/mg (10mg vial, $49.00)

Where is the cheapest place to buy Selank?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Ascension Peptides at $2.50/mg (10mg Lyophilized Vial, $25.00 after the 50% new-customer partner-link discount). We compared 11 US suppliers with live, checked prices.

How much does Selank cost per mg?

Verified US domestic prices currently range from $2.50/mg to $9.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Selank approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Related Peptides

Popular Stacks

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.